Related Experiment Videos

[The baby retraction reaction evaluation in pediatric diseases: a validity study]

Francisco Baptista Assumpção1, Tatiana Malheiros Assumpção

  • 1Departamento de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

Insights

The Behavior Assessment of Drug-related Symptoms (BADS) questionnaire shows no significant difference in withdrawal reactions between sick and healthy children. This validated scale is important for screening pediatric patients.

Area of Science:

  • Pediatric Psychology
  • Child Development
  • Clinical Assessment

Background:

  • Evaluating withdrawal reactions in young children requires considering their psychopathological context and developmental stage.
  • Standardized instruments are crucial for accurate assessment.

Purpose of the Study:

  • To validate the Behavior Assessment of Drug-related Symptoms (BADS) questionnaire.
  • To assess withdrawal reactions in pediatric patients aged 0-2 years.
  • To compare withdrawal reactions in sick versus healthy children.

Main Methods:

  • The BADS questionnaire was administered to 35 children (0-2 years) with pediatric diseases.
  • Results were compared to a previous study of 90 healthy children.
  • Independent t-test was used for statistical analysis.

Main Results:

  • Mean BADS scores were 5.90 ± 2.57 for normal children and 6.37 ± 4.83 for sick children.
  • The difference in scores was not statistically significant (p=0.651) at a 5% significance level.
  • Withdrawal reactions in sick children did not significantly differ from those in normal children.

Conclusions:

  • The BADS questionnaire is a valid screening instrument for assessing withdrawal reactions in young children.
  • The scale's findings suggest that illness does not significantly alter withdrawal reactions in this age group.
  • Further research may explore specific pediatric conditions and their impact on withdrawal symptoms.

Related Concept Videos